Tyr-Somatostatin-14

Send Inquiry
Tyr-Somatostatin-14
Details
•CAS Number: 58100-03-1
•Synonyms: [Tyr¹]-Somatostatin-14; Tyrosine somatostatin 14; SSTR targeting peptide
•Amino Acid Sequence: Tyr-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys (one-letter: YAGCKNFFWKTFTSC, Cys4-Cys15 disulfide-bridged cyclic)
•Peptide Length: 15 amino acids (Cys4-Cys15 disulfide-bridged cyclic, with N-terminal additional tyrosine)
•Purity (HPLC): ≥95%
Related Documents
•Certificate of Analysis (COA)
•Mass Spectrometry (MS) Report
•HPLC Purity Report
•Peptide Solubility and Storage Guide
Category
Drug Delivery Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of tyr-somatostatin-14 in China, also supports custom service. Welcome to wholesale bulk high quality tyr-somatostatin-14 from our factory. Contact us for more details.

 

Description Tyr-Somatostatin-14 is a somatostatin analog with an additional tyrosine residue at the N-terminus of native somatostatin-14 (Somatostatin-14, SST-14), CAS number 58100-03-1. The native somatostatin-14 sequence is AGCKNFFWKTFTSC (14aa, Cys3-Cys14 disulfide-bridged cyclic), and Tyr-Somatostatin-14 adds a tyrosine (Y) at its N-terminus, forming the 15-amino-acid YAGCKNFFWKTFTSC sequence (Cys4-Cys15 disulfide-bridged cyclic). Somatostatin is an important neuroendocrine regulatory peptide that exerts inhibitory effects on growth hormone, insulin, glucagon, and various gastrointestinal hormone secretion by binding to somatostatin receptors (SSTR1-5). The introduction of an N-terminal tyrosine provides a site for radioiodine labeling (such as ¹²⁵I, ¹³¹I) for this peptide, which can be used in receptor binding experiments, autoradiography, and in vivo SSTR expression imaging studies. Tyr-Somatostatin-14 retains high-affinity binding capability to SSTRs and is widely used in SSTR targeting research of neuroendocrine tumors (such as carcinoid tumors, islet cell tumors), receptor pharmacology experiments, and radiopharmaceutical development.
Molecular formula C₈₅H₁₁₃N₁₉O₂₁S₂
Molecular weight (Da) 1801.05
Structure type Cyclic peptide (Cys4-Cys15 disulfide bridge, N-terminal tyrosine-labeled somatostatin analog)
Solubility Freely soluble in water, PBS
Storage Condition Powder at -20°C, dry and protected from light

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Salt Form Length (aa)
Tyr-Somatostatin-14 Tyrosine-modified somatostatin-14; Tyr-SS-14 Somatostatin receptor ligand, neuropeptide, endocrine regulation, tumor imaging Native somatostatin-14 N-terminally modified with tyrosine, retaining high affinity for SSTR receptors; inhibits secretion of growth hormone and glucagon, and can be radioiodinated for imaging of receptor-positive tumors C₇₆H₁₀₄N₁₈O₁₉S₂ 1636.72 ~1637.9 Acetate 14

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-TYR-SS14 White powder Store at -20°C, sealed, dry and protected from light. Aliquot for storage. Stable for 1 month at 2–8°C in sealed dry condition; stable for shipping at ambient temperature. Stable for 7 days at 4°C. Soluble in dilute acetic acid and PBS. Intramolecular disulfide bond is sensitive to strong reducing agents and prone to cleavage and inactivation. Optimal receptor binding activity at physiological pH. Stable for 2 years at -20°C, dry and protected from light.

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-TYR-SS14 Tyrosine-modified somatostatin-14 for receptor binding and tumor imaging Tyr-Somatostatin-14 is a modified peptide with a tyrosine added to the N-terminus of native somatostatin-14. It fully retains high affinity for somatostatin receptors (SSTR1–5) and inhibits secretion of growth hormone, insulin and glucagon. The N-terminal tyrosine allows convenient radioiodination for imaging diagnosis and receptor research of SSTR-positive tumors. Endocrine disease research, tumor molecular imaging, neuropeptide research, receptor pharmacology, nuclear medicine diagnosis Somatostatin receptors (SSTR); GPCR signaling pathway; hormone secretion regulation

 

 

 

 

Hot Tags: tyr-somatostatin-14, China tyr-somatostatin-14 manufacturers, suppliers, factory, 203716-10-3, 651328-78-8, CAS 203716 10 3, CAS 395069 92 8, Tetralysine, therapeutic and pharmaceutical peptides

Send Inquiry